Thyroid hormone resistance syndrome. Inhibition of normal receptor function by mutant thyroid hormone receptors.

Thyroid hormone (T3) resistance is inherited in most cases in an autosomal dominant manner. The disorder is characterized by elevated free thyroid hormone levels and partial resistance to thyroid hormone at the cellular level. Distinct single amino acid substitutions in the ligand binding domain of the beta form of the thyroid hormone receptor have been described in two kindreds with this disorder. We used transient expression assays to characterize the functional properties of these receptor mutants, one containing a Gly to Arg change at amino acid 340 (G340R) and the other a Pro to His change at amino acid 448 (P448H). A nine amino acid carboxy terminal deletion (delta 448-456), analogous to an alteration that occurs in v-erbA, was also studied for comparison with the mutations that occur in the T3 resistance syndrome. None of the receptor mutants were able to mediate thyroid hormone dependent activation (TreTKCAT) or repression (TSH alpha CAT) of reporter genes when compared with the wild type receptor. In addition, the mutants inhibited the activity of normal alpha and beta receptor isoforms when examined in coexpression assays. This activity, referred to as dominant negative inhibition, was manifest with respect to both the positively and negatively regulated reporter genes. Although mutant receptor binding to DNA was unaffected, ligand binding studies showed that the G340R and delta 448-456 mutants failed to bind T3, whereas the P448H mutant bound hormone with reduced affinity (approximately 10% of normal) compared to the wild type receptor. Consistent with this finding, the P448H mutant receptor was partially active at higher T3 concentrations. Furthermore, the dominant negative inhibition elicited by the P448H receptor mutant at higher T3 concentrations was reversed in the presence of high doses of T3. These findings indicate that mutant beta receptors in patients with thyroid hormone resistance have reduced affinity for T3 and are functionally deficient, but impair the activity of normal receptors, thereby providing a mechanism for the dominant mode of inheritance in this disorder.

[1]  H. Samuels,et al.  A domain containing leucine-zipper-like motifs mediate novel in vivo interactions between the thyroid hormone and retinoic acid receptors. , 1989, Molecular endocrinology.

[2]  J. Yamakawa,et al.  Filter-binding assay procedure for thyroid hormone receptors. , 1983, Analytical biochemistry.

[3]  P. Larsen,et al.  Identification of a thyroid hormone receptor that is pituitary-specific. , 1989, Science.

[4]  F. Wondisford,et al.  Thyroid hormone and DNA binding properties of a mutant c-erbA beta receptor associated with generalized thyroid hormone resistance. , 1990, Biochemical and biophysical research communications.

[5]  M. Lazar,et al.  Thyroid hormone receptors form distinct nuclear protein-dependent and independent complexes with a thyroid hormone response element. , 1990, Molecular endocrinology.

[6]  Michael R. Green,et al.  Evidence for interaction of different eukaryotic transcriptional activators with distinct cellular targets , 1990, Nature.

[7]  I. Verma,et al.  Both the basic region and the ‘leucine zipper’ domain of the cyclic AMP response element binding (CREB) protein are essential for transcriptional activation. , 1990, The EMBO journal.

[8]  S. Seino,et al.  Generalized resistance to thyroid hormone associated with a mutation in the ligand-binding domain of the human thyroid hormone receptor beta. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[9]  B. O’Malley,et al.  Point mutations in the human vitamin D receptor gene associated with hypocalcemic rickets. , 1988, Science.

[10]  R. Evans,et al.  The c-erb-A gene encodes a thyroid hormone receptor , 1986, Nature.

[11]  J. Harney,et al.  Mutations of the rat growth hormone promoter which increase and decrease response to thyroid hormone define a consensus thyroid hormone response element. , 1989, Molecular endocrinology.

[12]  C. Glass,et al.  Positive and negative regulation of gene transcription by a retinoic acid-thyroid hormone receptor heterodimer , 1989, Cell.

[13]  M. Lazar,et al.  Regulation of two c-erbA messenger ribonucleic acids in rat GH3 cells by thyroid hormone. , 1988, Molecular endocrinology.

[14]  T. Kunkel.  Rapid and efficient site-specific mutagenesis without phenotypic selection. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[15]  J. Burnside,et al.  A nuclear factor that enhances binding of thyroid hormone receptors to thyroid hormone response elements. , 1990, The Journal of biological chemistry.

[16]  Klaus Damm,et al.  Protein encoded by v-erbA functions as a thyroid-hormone receptor antagonist , 1989, Nature.

[17]  S. Refetoff,et al.  Familial syndrome combining deaf-mutism, stuppled epiphyses, goiter and abnormally high PBI: possible target organ refractoriness to thyroid hormone. , 1967, The Journal of clinical endocrinology and metabolism.

[18]  B. Howard,et al.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells , 1982, Molecular and cellular biology.

[19]  B. Weintraub,et al.  Familial generalized resistance to thyroid hormones: report of three kindreds and correlation of patterns of affected tissues with the binding of [125I] triiodothyronine to fibroblast nuclei , 1986, Journal of endocrinological investigation.

[20]  L J Degroot,et al.  Negative and positive transcriptional regulation by thyroid hormone receptor isoforms. , 1990, Molecular endocrinology.

[21]  Tom Maniatis,et al.  Action of leucine zippers , 1989, Nature.

[22]  L. Degroot,et al.  Expression of three forms of thyroid hormone receptor in human tissues. , 1989, Molecular endocrinology.

[23]  M. Ptashne.  How eukaryotic transcriptional activators work , 1988, Nature.

[24]  F. Wondisford,et al.  A base mutation of the C-erbA beta thyroid hormone receptor in a kindred with generalized thyroid hormone resistance. Molecular heterogeneity in two other kindreds. , 1990, The Journal of clinical investigation.

[25]  F. Wondisford,et al.  Tight linkage between the syndrome of generalized thyroid hormone resistance and the human c-erbA beta gene. , 1988, Molecular endocrinology.

[26]  P. Chambon,et al.  Steroid hormone receptors compete for factors that mediate their enhancer function , 1989, Cell.

[27]  P. Larsen,et al.  Inhibition of thyroid hormone action by a non-hormone binding c-erbA protein generated by alternative mRNA splicing , 1989, Nature.

[28]  S. Izumo,et al.  Thyroid hormone receptor α isoforms generated by alternative splicing differentially activate myosin HC gene transcription , 1988, Nature.

[29]  G. Bell,et al.  Characterization of a third human thyroid hormone receptor coexpressed with other thyroid hormone receptors in several tissues. , 1988, Molecular endocrinology.

[30]  H. Samuels,et al.  Interactions among a subfamily of nuclear hormone receptors: the regulatory zipper model. , 1990, Molecular endocrinology.

[31]  J. Jameson,et al.  Negative regulation of the thyroid-stimulating hormone a gene by thyroid hormone : Receptor interaction adjacent to the TATA box ( glycoprotein hormones / erbA protooncogene / gene transcription / steroid receptors ) , 2022 .